Mazer R Ally, John D Betteridge, Ganesh R Veerappan. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultAntibodies, Monoclonal/adverse effectsCrohn Disease/drug therapyDermatologic Agents/adverse effectsHumansHypersensitivity, Delayed/chemically inducedInfliximabMalePrognosis
Substances: See more » Antibodies, MonoclonalDermatologic AgentsInfliximab
Year: 2012 PMID: 22231796 DOI: 10.1002/ibd.21909
Source DB: PubMed Journal: Inflamm Bowel Dis ISSN: 1078-0998 Impact factor: 5.325